Medicare Enrolled
Dr. Nathan Steinle, M.D.
Ophthalmology · Santa Barbara, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Steinle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Steinle?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Steinle
Dr. Nathan Steinle is an ophthalmology specialist in Santa Barbara, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Steinle performed 84,491 Medicare services across 11,915 unique beneficiaries.
Between the years covered by Open Payments, Dr. Steinle received a total of $1,087,258 from 32 pharmaceutical and/or device companies across 924 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Steinle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 0% volume in CA
$1,087,258 industry payments
Medicare Practice Summary
Medicare Utilization ↗84,491
Medicare services
Top 0% in CA for ophthalmology
11,915
Unique beneficiaries
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,970 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
39,420 | $29 | $65 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
8,663 | $33 | $125 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
6,369 | $102 | $177 |
| Ranibizumab-eqrn injection, 0.1 mg An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose. |
6,023 | $217 | $795 |
| Ranibizumab-nuna biosimilar injection, 0.1 mg An injection of the biosimilar medication ranibizumab-nuna (Byooviz) at a dose of 0.1 mg. |
4,540 | $176 | $395 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
4,470 | $114 | $1,001 |
| Aflibercept eye injection (Eylea) | 4,128 | $689 | $1,260 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
3,390 | $120 | $402 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
2,495 | $12 | $200 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
675 | $19 | $200 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
561 | $1,583 | $3,318 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
483 | $156 | $480 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
422 | $29 | $97 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
393 | $77 | $125 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
356 | $1 | $10 |
| Injection, ranibizumab, 0.1 mg | 336 | $173 | $503 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
254 | $120 | $182 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
253 | $127 | $220 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
251 | $72 | $115 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
196 | $107 | $237 |
| Laser vitreolysis A laser procedure used to destroy fluid in the vitreous of the eye, located between the lens and the retina. |
108 | $799 | $4,556 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
80 | $263 | $1,600 |
| Injection into eye membrane A procedure involving the injection of a drug or substance into the membrane that covers the eyeball. |
80 | $41 | $208 |
| Removal of recurring cataract in lens capsule A surgical procedure to remove a recurrent cataract by making a stab incision in the lens capsule. |
79 | $210 | $800 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
79 | $39 | $226 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
70 | $946 | $4,586 |
| Fluorescein angiography of the eye An imaging test of the front part of the eye using a special camera after a dye is injected to visualize blood flow. |
60 | $128 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
39 | $105 | $171 |
| Laser repair of detached retina A procedure that uses a laser to seal and reattach a detached retina to the back of the eye. |
35 | $246 | $1,600 |
| Retinal laser treatment for leaking blood vessels This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels. |
30 | $284 | $1,737 |
| Retinal detachment repair with fluid drainage A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina. |
25 | $1,005 | $4,798 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
22 | $216 | $1,730 |
| Complex detached retina repair with eye fluid drainage A surgical procedure to repair a detached retina and drain fluid located between the lens and the retina. |
18 | $1,052 | $4,854 |
| New patient office visit, complex (60-74 min) | 18 | $185 | $250 |
| Removal of implanted eye lens This procedure involves the surgical removal of an artificial lens that has been implanted in the eye. |
15 | $362 | $1,760 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
15 | $687 | $4,360 |
| Laser destruction of vitreous and retina A laser procedure used to destroy fluid in the vitreous and tissue across the entire retina. |
15 | $831 | $4,594 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $94 | $199 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $41 | $94 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,087,258
Total received (2018-2024)
Avg $155,323/year across 7 years
Top 0% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
924
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,001,576 (92.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$63,349 (5.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,078 (2.0%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$255 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$137,030
2023
$250,021
2022
$250,875
2021
$78,383
2020
$46,867
2019
$217,703
2018
$106,380
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$67,954
Apellis Pharmaceuticals, Inc.
$50,014
Roche Products Limited
$12,495
Genentech USA, Inc.
$2,638
ABBVIE INC.
$2,126
Alimera Sciences, Inc.
$1,410
Bausch & Lomb Americas Inc.
$117
Alcon Vision LLC
$116
Astellas Pharma US Inc
$63
Harrow Eye, LLC
$35
Biogen, Inc.
$34
Regeneron Pharmaceuticals, Inc.
$27
Top 3 companies account for 95.2% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$461,203
Genentech USA, Inc.
$181,386
Apellis Pharmaceuticals, Inc.
$171,259
Novartis Pharmaceuticals Corporation
$91,354
Biogen, Inc.
$78,847
Roche Products Limited
$30,769
Bausch & Lomb Americas Inc.
$17,866
NOVARTIS PHARMACEUTICALS CORPORATION
$10,187
F. Hoffmann-La Roche AG
$7,928
Alimera Sciences, Inc.
$7,528
Amgen Inc.
$4,915
Regeneron Pharmaceuticals, Inc.
$4,548
Carl Zeiss Meditec, Inc.
$4,077
Genentech, Inc.
$3,883
ABBVIE INC.
$3,794
Bausch & Lomb, a division of Bausch Health US, LLC
$2,624
Oyster Point Pharma, Inc.
$1,922
Allergan, Inc.
$1,045
Alcon Vision LLC
$668
Allergan Inc.
$283
Ocular Therapeutix, Inc.
$262
US Retina LLC
$255
Astellas Pharma US Inc
$140
AbbVie Inc.
$104
Mallinckrodt LLC
$91
Aerie Pharmaceuticals, Inc.
$89
Hoffmann-La Roche Limited
$70
NEW WORLD MEDICAL,INC.
$60
Harrow Eye, LLC
$35
Sight Sciences, Inc.
$30
EyePoint Pharmaceuticals US, Inc.
$23
Spark Therapeutics, Inc.
$14
Top 3 companies account for 74.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Ahmed Glaucoma Valve · BEOVU · BYOOVIZ · CLARUS · Constellation · DEXTENZA · DEXYCU · DOCTORS ALLERGY FORMULA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · FLAREX · ILUVIEN · Iluvien · Izervay · LOTEMAX SM · LUMIGAN · LUXTURNA · Lucentis · Non-Covered Product · OMNI(R) SURGICAL SYSTEM (US) · OZURDEX · PROLENSA · SUSVIMO · Syfovre · TYRVAYA · VABYSMO · VISUDYNE · VUITY · VYZULTA · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for ophthalmology in CA.
Geographic Context
Ophthalmologists within 10 mi
21
Per 100K population
4.7
County median income
$95,977
Nearest hospital
SANTA BARBARA COUNTY PSYCHIATRIC HEALTH FACILITY
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Steinle is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Steinle experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Steinle performed 39,420 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Steinle receive payments from pharmaceutical companies?
Yes. Dr. Steinle received a total of $1,087,258 from 32 companies across 924 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Steinle's costs compare to other ophthalmologists in Santa Barbara?
Dr. Steinle's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Steinle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Santa Barbara
Browse ophthalmologists in Santa Barbara ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in CA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in CA
Which CA ophthalmologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Apellis Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Apellis Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology